Rocket Pharmaceuticals Files 8-K
Ticker: RCKTW · Form: 8-K · Filed: May 27, 2025 · CIK: 1281895
| Field | Detail |
|---|---|
| Company | Rocket Pharmaceuticals, Inc. (RCKTW) |
| Form Type | 8-K |
| Filed Date | May 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-disclosure, filing
TL;DR
Rocket Pharma filed an 8-K on 5/27/25, confirming corporate details and past name changes.
AI Summary
Rocket Pharmaceuticals, Inc. filed an 8-K on May 27, 2025, reporting on Regulation FD Disclosure and Financial Statements and Exhibits. The filing confirms the company's name, incorporation in Delaware, and its principal executive offices located at 9 Cedarbrook Drive, Cranbury, NJ 08512. The report also notes a former company name, Inotek Pharmaceuticals Corp, with a name change date of February 26, 2004.
Why It Matters
This 8-K filing serves as an official record of corporate events and disclosures for Rocket Pharmaceuticals, Inc., providing transparency to investors and the public.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Rocket Pharmaceuticals, Inc. (company) — Registrant
- May 27, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 9 Cedarbrook Drive, Cranbury, NJ 08512 (address) — Principal Executive Offices
- Inotek Pharmaceuticals Corp (company) — Former Company Name
- February 26, 2004 (date) — Date of Name Change
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report for Rocket Pharmaceuticals, Inc., primarily for Regulation FD Disclosure and reporting Financial Statements and Exhibits.
When was the report filed and what is the earliest event date reported?
The report was filed on May 27, 2025, and the date of the earliest event reported is also May 27, 2025.
In which state is Rocket Pharmaceuticals, Inc. incorporated?
Rocket Pharmaceuticals, Inc. is incorporated in Delaware.
What is the address of Rocket Pharmaceuticals, Inc.'s principal executive offices?
The principal executive offices are located at 9 Cedarbrook Drive, Cranbury, NJ 08512.
What was the company's former name and when did the name change occur?
The company's former name was Inotek Pharmaceuticals Corp, and the date of the name change was February 26, 2004.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 27, 2025 regarding ROCKET PHARMACEUTICALS, INC. (RCKTW).